Publikationen in Zusammenarbeit mit Forschern von Vall d'Hebron Institut de Recerca (48)

2024

  1. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

    Heliyon, Vol. 10, Núm. 10

  2. EPITRANS. Quality assessment of the epilepsy transition process

    European Journal of Paediatric Neurology, Vol. 48, pp. 121-128

  3. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

  4. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

  5. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

  6. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?

    European Child and Adolescent Psychiatry, Vol. 33, Núm. 3, pp. 799-810

  7. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research, Vol. 267, pp. 534-545

  8. Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode

    Psychoneuroendocrinology, Vol. 169

  9. The impact of sex in the effectiveness of functional remediation in bipolar disorder

    Acta Psychiatrica Scandinavica

  10. The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysis

    European Psychiatry

2023

  1. Complex post-traumatic stress disorder (CPTSD) of ICD-11 in youths with childhood maltreatment: Associations with age of exposure and clinical outcomes

    Journal of Affective Disorders, Vol. 332, pp. 92-104

  2. Corrigendum: Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (Front. Psychiatry, (2022), 13, 982583, 10.3389/fpsyt.2022.982583)

    Frontiers in Psychiatry

  3. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

    Psychiatry Research, Vol. 325

  4. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental

  5. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode

    Psychological Medicine, Vol. 53, Núm. 10, pp. 4634-4647

  6. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  7. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  8. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

  9. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

2022

  1. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 243, pp. 32-42